Roselle Calyx (Hibiscus sabdariffa L.) Ethyl Acetate Fraction Lowering Malondialdehyde and TNF-α and Reducing Hypercoagulability in Diabetic Model
Pharmacology · 2024
DOI: 10.1159/000538362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology, 2024. Verfasst von Rahmad Abdillah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departement of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas University, Padang, Indonesia, rahmadabdillah@phar.unand.ac.id. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Hibiscus, Tumor Necrosis Factor-alpha, Malondialdehyde. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
Traditionally and empirically, Hibiscus sabdariffa L. has been used in treating diabetes mellitus due to its antioxidant activity. This study aimed to investigate the effect of administering the ethyl acetate fraction of hibiscus calyxes (EAFHCs) on malondialdehyde (MDA) levels, tumor necrosis factor-α (TNF-α) levels, bleeding time, and platelet count in male white rats induced with streptozotocin-induced diabetes.
Method
Thirty-six Wistar Kyoto rats were induced with intraperitoneal streptozotocin at 55 mg/kg BW and stabilized for 5 days to obtain diabetic conditions. Diabetic animals were divided into four groups; the diabetic group was given vehicle, the glibenclamide group was given 0.45 mg/kg BW of glibenclamide, and two groups were administered the EAFHCs at doses of 100 mg/kg BW and 200 mg/kg BW for 5 days. Subsequently, the MDA, TNF-α, bleeding time and platelet count levels were examined on days 1, 3, and 5, respectively. All data were analyzed using two-way ANOVA followed by the Duncan Multiple Range Test (DMRT).
Results
EAFHC significantly reduced MDA and TNF-α levels (p < 0.05). Additionally, this fraction appeared to shorten bleeding time and decrease platelet count in diabetic rats. Administration of the EAFHC for 5 days effectively lowered MDA and TNF-α levels significantly, decreased platelet counts and prolonged coagulation (p < 0.05) in diabetic rats.
Conclusion
This study demonstrates that EAFHC effectively reduces MDA and TNF-α levels and reduces the risk of hypercoagulability in diabetic model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departement of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas University, Padang, Indonesia, rahmadabdillah@phar.unand.ac.id.
- Undergraduate Pharmacy Study Program Faculty of Pharmacy Andalas University, Padang, Indonesia.
- Departement of Pharmaceutical Biology and Natural Product, Faculty of Pharmacy, Andalas University, Padang, Indonesia.
- Departement of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas University, Padang, Indonesia.
Zitieren
APA
Abdillah, R., Maulina, M., Rahmatika, A., Suharti, N., & Armenia, A. (2024). Roselle Calyx (Hibiscus sabdariffa L.) Ethyl Acetate Fraction Lowering Malondialdehyde and TNF-α and Reducing Hypercoagulability in Diabetic Model. Pharmacology. https://doi.org/10.1159/000538362
Vancouver
Abdillah R, Maulina M, Rahmatika A, Suharti N, Armenia A. Roselle Calyx (Hibiscus sabdariffa L.) Ethyl Acetate Fraction Lowering Malondialdehyde and TNF-α and Reducing Hypercoagulability in Diabetic Model. Pharmacology. 2024. doi:10.1159/000538362
BibTeX
@article{Abdillah2024,
author = {Abdillah, Rahmad and Maulina, Milla and Rahmatika, Afni and Suharti, Netty and Armenia, Armenia},
title = {Roselle Calyx (Hibiscus sabdariffa L.) Ethyl Acetate Fraction Lowering Malondialdehyde and TNF-α and Reducing Hypercoagulability in Diabetic Model},
journal = {Pharmacology},
year = {2024},
doi = {10.1159/000538362}
}
EUVIMED